Feifei Pu

1.4k total citations
71 papers, 963 citations indexed

About

Feifei Pu is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Feifei Pu has authored 71 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 25 papers in Surgery and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Feifei Pu's work include Sarcoma Diagnosis and Treatment (12 papers), Cancer-related molecular mechanisms research (10 papers) and Management of metastatic bone disease (10 papers). Feifei Pu is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Cancer-related molecular mechanisms research (10 papers) and Management of metastatic bone disease (10 papers). Feifei Pu collaborates with scholars based in China, United States and United Kingdom. Feifei Pu's co-authors include Zengwu Shao, Fengxia Chen, Zengwu Shao, Baichuan Wang, Jianxiang Liu, Doudou Jing, Haoyu Guo, Xin Huang, Zhicai Zhang and Lutong Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Feifei Pu

67 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Feifei Pu China	17	422	249	199	142	126	71	963
Li Teng China	20	435 1.0×	150 0.6×	297 1.5×	248 1.7×	102 0.8×	85	1.4k
Sheng‐Zhong Duan China	22	545 1.3×	122 0.5×	192 1.0×	122 0.9×	126 1.0×	68	1.3k
Baoping Xu China	12	305 0.7×	163 0.7×	140 0.7×	90 0.6×	59 0.5×	32	791
Jie Cheng China	21	467 1.1×	160 0.6×	148 0.7×	111 0.8×	99 0.8×	86	1.2k
Zhenzhen Jiang China	18	692 1.6×	354 1.4×	217 1.1×	114 0.8×	135 1.1×	61	1.4k
Bing Tu China	18	429 1.0×	232 0.9×	290 1.5×	246 1.7×	76 0.6×	46	1.2k
Jinrong Lin China	19	393 0.9×	175 0.7×	244 1.2×	103 0.7×	73 0.6×	61	989
Meng Fan China	16	497 1.2×	228 0.9×	176 0.9×	63 0.4×	91 0.7×	74	930
Yohei Yamamoto Japan	17	393 0.9×	121 0.5×	156 0.8×	68 0.5×	103 0.8×	67	986

Countries citing papers authored by Feifei Pu

Since Specialization

Citations

This map shows the geographic impact of Feifei Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Pu more than expected).

Fields of papers citing papers by Feifei Pu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Pu. The network helps show where Feifei Pu may publish in the future.

Co-authorship network of co-authors of Feifei Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Pu. A scholar is included among the top collaborators of Feifei Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Pu. Feifei Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pu, Feifei, et al.. (2025). Has-miR-30c-1-3p inhibits macrophage autophagy and promotes Mycobacterium tuberculosis survival by targeting ATG4B and ATG9B. Scientific Reports. 15(1). 10240–10240. 1 indexed citations

Feng, Jing, et al.. (2024). Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma. Genes & Diseases. 12(4). 101335–101335. 4 indexed citations

Xia, Ping, Xiaolong Zhao, Songfeng Chen, et al.. (2023). Anterior debridement combined with autogenous iliac bone graft fusion for the treatment of lower cervical tuberculosis: a multicenter retrospective study. Journal of Orthopaedics and Traumatology. 24(1). 48–48. 1 indexed citations

Pu, Feifei, et al.. (2023). Clinical effect of surgical resection on primary malignant and invasive bone tumours of the proximal fibula. Molecular and Clinical Oncology. 18(4). 27–27. 2 indexed citations

Cao, Li, Wei Wu, Xiangyu Deng, et al.. (2023). Association between total cholesterol and total bone mineral density in US adults: National Health and Nutrition Examination Survey (NHANES), 2011–2018. Journal of Orthopaedic Surgery and Research. 18(1). 40–40. 11 indexed citations

Pu, Feifei, et al.. (2023). Diagnosis and Treatment of Bone Metastases. Frontiers research topics. 1 indexed citations

Pu, Feifei, et al.. (2023). Clinical efficacy of customized modular prosthesis in the treatment of femoral shaft metastases. Frontiers in Oncology. 13. 1115898–1115898.

Shi, Deyao, Shidai Mu, Feifei Pu, et al.. (2022). Pan-sarcoma characterization of lncRNAs in the crosstalk of EMT and tumour immunity identifies distinct clinical outcomes and potential implications for immunotherapy. Cellular and Molecular Life Sciences. 79(8). 427–427. 3 indexed citations

Pu, Feifei, Deyao Shi, Ting Chen, et al.. (2021). SP1-induced long non-coding RNA SNHG6 facilitates the carcinogenesis of chondrosarcoma through inhibiting KLF6 by recruiting EZH2. Cell Death and Disease. 12(1). 59–59. 15 indexed citations

10.

Pu, Feifei, et al.. (2021). Total sacrectomy with a combined antero-posterior surgical approach for malignant sacral tumours. International Orthopaedics. 45(5). 1347–1354. 10 indexed citations

11.

Liu, Jianxiang, Feifei Pu, Qiang Wu, et al.. (2017). In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma. Medicine. 96(27). e7245–e7245. 26 indexed citations

12.

Chen, Fengxia & Feifei Pu. (2017). Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review. OncoTargets and Therapy. Volume 10. 2009–2016. 3 indexed citations

13.

Wang, Baichuan, Yongqiang Hao, Feifei Pu, Wenbo Jiang, & Zengwu Shao. (2017). Computer-aided designed, three dimensional-printed hemipelvic prosthesis for peri-acetabular malignant bone tumour. International Orthopaedics. 42(3). 687–694. 78 indexed citations

14.

Wang, Baichuan, et al.. (2017). Presacral Tarlov Cyst as an Unusual Cause of Abdominal Pain: New Case and Literature Review. World Neurosurgery. 110. 79–84. 14 indexed citations

15.

Pu, Feifei, Fengxia Chen, & Zengwu Shao. (2016). MicroRNAs as biomarkers in the diagnosis and treatment of chondrosarcoma. Tumor Biology. 37(12). 15433–15436. 10 indexed citations

16.

Chen, Fengxia, et al.. (2016). Association between a functional variant in RAD51 gene’s 3′ untranslated region and its mRNA expression in lymphoblastoid cell lines. SpringerPlus. 5(1). 1688–1688. 8 indexed citations

17.

Shao, Zengwu, Feifei Pu, Fengxia Chen, et al.. (2016). The synergistic anticancer effect of cisplatin combined with Oldenlandia diffusa in osteosarcoma MG-63 cell line in vitro. OncoTargets and Therapy. 9. 255–255. 17 indexed citations

18.

Pu, Feifei, Baichuan Wang, Jianxiang Liu, Fengxia Chen, & Zengwu Shao. (2016). Giant chordoma in the thoracolumbar spine: a case report and literature review. European Spine Journal. 26(S1). 95–99. 4 indexed citations

19.

Shao, Zengwu, et al.. (2015). Association between GSTP1 polymorphisms and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis. OncoTargets and Therapy. 8. 1835–1835. 8 indexed citations

20.

Shao, Nannan, et al.. (2014). Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(6). 889–895. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact